By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Drugs > Sodium chloride (monograph) > Bacteriostatic Sodium Chloride Prescribing Information
Drugs
https://themeditary.com/pro/bacteriostatic-sodium-chloride-prescribing-information-15151.html

Bacteriostatic Sodium Chloride Prescribing Information

Drug Detail:Sodium chloride (monograph) (Medically reviewed)

Drug Class:

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Multiple-dose Plastic Vial

Multiple-dose LifeShield® Plastic Vial

NOT FOR INHALATION

Rx only

WARNING: NOT FOR USE IN NEONATES.

Bacteriostatic Sodium Chloride Description

This preparation is designed for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection.

Bacteriostatic 0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution of sodium chloride in water for injection. Each milliliter (mL) contains sodium chloride 9 mg and 0.9% (9 mg/mL) benzyl alcohol added as a bacteriostatic preservative. May contain hydrochloric acid for pH adjustment. It is supplied in a multiple-dose container from which repeated withdrawals may be made to dilute or dissolve drugs for medication. The pH is 5.0 (4.5 to 7.0).

Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water.

The semi-rigid vial is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper drug concentration.

Bacteriostatic Sodium Chloride - Clinical Pharmacology

Sodium chloride in water dissociates to provide sodium (Na+) and chloride (Cl−) ions. These ions are normal constituents of the body fluids (principally extracellular) and are essential for maintaining electrolyte balance.

The distribution and excretion of sodium (Na+) and chloride (Cl−) are largely under the control of the kidney which maintains a balance between intake and output.

The small volume of fluid and amount of sodium chloride provided by Bacteriostatic 0.9% Sodium Chloride Injection, USP, when used only as a vehicle for parenteral injection of drugs, is unlikely to exert a significant effect on fluid and electrolyte balance except possibly in neonates and very small infants.

Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).

Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.

Related/similar drugs

sodium chloride, NebuSal, Hyper-Sal

Indications and Usage for Bacteriostatic Sodium Chloride

This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

Contraindications

Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population.

Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement.

Parenteral preparations containing benzyl alcohol should not be used in epidural or spinal anesthetic procedures.

Warnings

Benzyl alcohol, a preservative in Bacteriostatic Sodium Chloride Injection, USP has been associated with toxicity in neonates. Data are unavailable on the toxicity of other preservatives in this age group. Preservative-free Sodium Chloride Injection should be used for flushing intravascular catheters. Where a sodium chloride solution is required for preparing or diluting medications for use in neonates, only preservative-free Sodium Chloride Injection should be used.

Precautions

Consult the manufacturer's instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection.

Inspect reconstituted (diluted or dissolved) drugs for clarity (if soluble) and freedom from unexpected precipitation or discoloration prior to administration.

Pregnancy

Animal reproduction studies have not been conducted with Bacteriostatic 0.9% Sodium Chloride Injection, USP. It is also not known whether Bacteriostatic 0.9% Sodium Chloride Injection containing additives can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Bacteriostatic 0.9% Sodium Chloride Injection containing additives should be given to a pregnant woman only if clearly needed.

Pediatric Use

The safety and effectiveness in the pediatric population are based on the similarity of the clinical conditions of the pediatric and adult populations. However, due to potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol are contraindicated in this patient population.

Drug Interactions

Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol. Consult with pharmacist, if available.

Use aseptic technique for single or multiple entry and withdrawal from all containers.

When diluting or dissolving drugs, mix thoroughly and use promptly.

Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute.

Do not use unless the solution is clear and seal intact.

Adverse Reactions/Side Effects

Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.

Although adverse reactions to intravenous, intramuscular or subcutaneous injection of 0.9% benzyl alcohol are not known to occur in man, experimental studies of small volume parenteral preparations containing 0.9% benzyl alcohol in several species of animals have indicated that an estimated intravenous dose up to 30 mL may be safely given to an adult without toxic effects. Administration of an estimated 9 mL to a 6 kg neonate or infant is potentially capable of producing blood pressure changes.

Overdosage

Use only as a diluent or solvent. This parenteral preparation is unlikely to pose a threat of sodium chloride or fluid overload except possibly in neonates and very small infants. In the event these should occur, re-evaluate the patient and institute appropriate corrective measures. See PRECAUTIONS and ADVERSE REACTIONS.

Bacteriostatic Sodium Chloride Dosage and Administration

The volume of the preparation to be used for diluting or dissolving any drug for injection, is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

How is Bacteriostatic Sodium Chloride supplied

Bacteriostatic 0.9% Sodium Chloride Injection, USP is supplied as:

Unit of SaleConcentration
NDC 0409-1966-050.9% (20 mL)
Tray of 25 Multiple-dose Plastic Fliptop Vials
NDC 0409-1966-070.9% (30 mL)
Tray of 25 Multiple-dose Plastic Fliptop Vials
NDC 0409-1966-120.9% (10 mL)
Tray of 25 Multiple-dose LifeShield® Plastic Fliptop Vials

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

LIFESHIELD® is the trademark of ICU Medical, Inc. and is used under license.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA Hospira Logo

LAB-1096-3.0

Revised: 02/2019

PRINCIPAL DISPLAY PANEL - 30 mL Vial Label

30 mL Multiple-dose
Bacteriostatic
0.9% Sodium
Chloride

Injection, USP

Hospira

LOT ##–###–AA

EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 30 mL Vial Label

PRINCIPAL DISPLAY PANEL - 30 mL Vial Tray

30 mL Multiple-dose Fliptop Vial

Bacteriostatic
0.9% Sodium
Chloride
Injection, USP

Rx only
NDC 0409-1966-07
Contains 25 of NDC 0409-1966-02

NOT FOR INHALATION

WARNING: NOT FOR
USE IN NEONATES.

FOR DRUG DILUENT USE ONLY.

Hospira

PRINCIPAL DISPLAY PANEL - 30 mL Vial Tray

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

10 mL Multiple-dose LifeShield® Vial
Bacteriostatic
0.9% Sodium
Chloride
Injection, USP

LOT ##–###–AA

EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray

10 mL Multiple-dose LifeShield® Vial

Bacteriostatic
0.9% Sodium
Chloride
Injection, USP

Rx only
NDC 0409-1966-12
Contains 25 of NDC 0409-1966-06

NOT FOR INHALATION.

WARNING: NOT FOR
USE IN NEONATES.

FOR DRUG DILUENT USE ONLY.

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray

PRINCIPAL DISPLAY PANEL - 20 mL Vial Label

20 mL Multiple-dose
Bacteriostatic
0.9% Sodium
Chloride

Injection, USP

Hospira

LOT ##–###–AA

EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 20 mL Vial Label

PRINCIPAL DISPLAY PANEL - 20 mL Vial Tray

20 mL Multiple-dose Fliptop Vial

Bacteriostatic
0.9% Sodium
Chloride
Injection, USP

Rx only
NDC 0409-1966-05
Contains 25 of NDC 0409-1966-01

NOT FOR INHALATION

WARNING: NOT FOR
USE IN NEONATES.

FOR DRUG DILUENT USE ONLY.

Hospira

PRINCIPAL DISPLAY PANEL - 20 mL Vial Tray
BACTERIOSTATIC SODIUM CHLORIDE
sodium chloride injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0409-1966
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37) SODIUM CHLORIDE9 mg in 1 mL
Inactive Ingredients
Ingredient NameStrength
BENZYL ALCOHOL (UNII: LKG8494WBH) 9 mg in 1 mL
HYDROCHLORIC ACID (UNII: QTT17582CB)
WATER (UNII: 059QF0KO0R)
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0409-1966-0725 in 1 TRAY04/30/2005
1NDC:0409-1966-0230 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
2NDC:0409-1966-1225 in 1 TRAY10/07/2005
2NDC:0409-1966-0610 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
3NDC:0409-1966-0525 in 1 TRAY05/02/2005
3NDC:0409-1966-0120 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA01880004/30/2005
Labeler - Hospira, Inc. (141588017)
Establishment
NameAddressID/FEIBusiness Operations
Hospira, Inc.093132819ANALYSIS(0409-1966) , LABEL(0409-1966) , MANUFACTURE(0409-1966) , PACK(0409-1966)
Establishment
NameAddressID/FEIBusiness Operations
Hospira, Inc.827731089ANALYSIS(0409-1966)
Establishment
NameAddressID/FEIBusiness Operations
Pfizer Healthcare India Private Limited860037912ANALYSIS(0409-1966) , LABEL(0409-1966) , MANUFACTURE(0409-1966) , PACK(0409-1966)

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by